Gastroenterology Associates of Colorado Springs Revenue and Competitors
Estimated Revenue & Valuation
- Gastroenterology Associates of Colorado Springs's estimated annual revenue is currently $4.2M per year.
- Gastroenterology Associates of Colorado Springs's estimated revenue per employee is $189,000
Employee Data
- Gastroenterology Associates of Colorado Springs has 22 Employees.
- Gastroenterology Associates of Colorado Springs grew their employee count by -4% last year.
Gastroenterology Associates of Colorado Springs's People
Name | Title | Email/Phone |
---|---|---|
1 | Nurse Manager- Endoscopy | Reveal Email/Phone |
Gastroenterology Associates of Colorado Springs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.2M | 1093 | 15% | N/A | N/A |
#2 | $13M | 177 | 18% | N/A | N/A |
#3 | $15.8M | 65 | 23% | N/A | N/A |
#4 | $7.8M | 36 | 0% | N/A | N/A |
#5 | $111.4M | 330 | 5% | N/A | N/A |
#6 | $176.9M | 524 | 17% | N/A | N/A |
#7 | $2426.8M | 6420 | 1105% | N/A | N/A |
#8 | $8M | 37 | 16% | N/A | N/A |
#9 | $5.1M | 27 | -16% | N/A | N/A |
#10 | $8M | 37 | 3% | N/A | N/A |
What Is Gastroenterology Associates of Colorado Springs?
4 Board Certified Physicians and 4 Nurse Practitioners Specializing in - Prevention of Colon Cancer - Disorders of the Esophagus, Stomach, and Intestines - State-of-the-Art Endoscopy Centers - Liver and Pancreatic Disease - Non-Surgical Treatment of Hemorrhoids Performing Over 9000 Procedures a Year Our Board Certified Gastroenterologists and Nurse Practitioners look forward to providing you with superior care!
keywords:N/AN/A
Total Funding
22
Number of Employees
$4.2M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 22 | -15% | N/A |
#2 | $2.3M | 22 | 0% | N/A |
#3 | $2.2M | 22 | 5% | N/A |
#4 | $4.2M | 22 | -12% | N/A |
#5 | $2.3M | 22 | -12% | N/A |